Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway
- PMID: 22167321
- DOI: 10.1007/s10549-011-1905-4
Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway
Abstract
Microarray-based techniques are being useful to obtain miRNA and gene expression signatures associated with different tumors. BRCA1 deregulation is a frequent event in the pathogenesis of breast as well as other cancers. In addition to DNA repair functions of BRCA1, it is involved in a wide range of cellular processes such as cell cycle, chromatin remodeling or transcription. However, the molecular events underlying BRCA1-associated tumorigenesis are still largely unknown. In order to deepen our understanding of BRCA1-associated tumorigenesis, we integrated data from mRNA and miRNA microarray experiments on HCC1937 breast cancer cell line, and the isogenic HCC1937 stably expressing BRCA1, to obtain significant miRNA-mRNA relationships associated with the presence of BRCA1 gene. By using bioinformatic integration of gene and miRNA expression data, we found significant miRNA-gene relationships underlying the array signatures. We additionally evaluated the role of these statistically significant pairs at the biological pathways level and identified MAPK and NF-κB pathways associated with these expression changes. Furthermore, we experimentally validated miRNAs induced by BRCA1 that commonly regulate TRAF2, a key regulator of NF-κB and MAPK pathways. We demonstrate that miR-146a, miR-99b and miR-205, induced in HCC1937 BRCA1-expressing cells, bind and regulate TRAF2 gene. In addition, re-expression of miR-146a, miR-99b or miR-205 in HCC1937 BRCA1-null cells was sufficient to modulate NF-κB activity. Our results demonstrate that integration of mRNA and miRNA associated with BRCA1 expression was useful to discover new miRNA-gene interactions as molecular events underlying BRCA1-mediated tumorigenesis.
Similar articles
-
Interplay between microRNAs and the STAT3 signaling pathway in human cancers.Physiol Genomics. 2013 Dec 15;45(24):1206-14. doi: 10.1152/physiolgenomics.00122.2013. Epub 2013 Nov 5. Physiol Genomics. 2013. PMID: 24192393 Review.
-
The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.J Hum Genet. 2012 Sep;57(9):556-63. doi: 10.1038/jhg.2012.75. Epub 2012 Jun 21. J Hum Genet. 2012. PMID: 22718022 Review.
-
MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.Cancer Res. 2010 Dec 1;70(23):9570-80. doi: 10.1158/0008-5472.CAN-10-2074. Epub 2010 Nov 30. Cancer Res. 2010. PMID: 21118966
-
Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709. Genes Chromosomes Cancer. 2009. PMID: 19760605
-
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.Int J Oncol. 2004 Mar;24(3):591-608. Int J Oncol. 2004. PMID: 14767544
Cited by
-
High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer.Am J Cancer Res. 2022 Oct 15;12(10):4840-4852. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381329 Free PMC article.
-
MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.Front Oncol. 2020 Oct 23;10:591181. doi: 10.3389/fonc.2020.591181. eCollection 2020. Front Oncol. 2020. PMID: 33194751 Free PMC article. Review.
-
Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype.Cancers (Basel). 2020 Nov 7;12(11):3298. doi: 10.3390/cancers12113298. Cancers (Basel). 2020. PMID: 33171872 Free PMC article. Review.
-
Integrative Bioinformatics and Functional Analyses of GEO, ENCODE, and TCGA Reveal FADD as a Direct Target of the Tumor Suppressor BRCA1.Int J Mol Sci. 2018 May 14;19(5):1458. doi: 10.3390/ijms19051458. Int J Mol Sci. 2018. PMID: 29757984 Free PMC article.
-
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis.Sci Rep. 2018 Jan 8;8(1):39. doi: 10.1038/s41598-017-18327-5. Sci Rep. 2018. PMID: 29311633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous